Clinical Trials Directory

Trials / Completed

CompletedNCT06214702

Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia

Deregulated Serum Levels of Serpin C and Soluble Fms-like Tyrosine Kinase-1 Might Predict the Development of Preeclampsia in Normotensive Pregnant Women

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Benha University · Academic / Other
Sex
Female
Age
25 Years – 45 Years
Healthy volunteers
Accepted

Summary

Evaluation of the predictability of estimated levels of Serpin C, sFlt-1 and placental growth factor (PLGF) in blood samples obtained during the 1st trimester from normotensive pregnant women for identification of women liable to develop PE during the course of pregnancy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTELISAELISA estimation of PLGF, sFlt-1 and Serpin C

Timeline

Start date
2023-01-07
Primary completion
2023-05-12
Completion
2023-11-15
First posted
2024-01-22
Last updated
2024-01-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06214702. Inclusion in this directory is not an endorsement.

Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Pre (NCT06214702) · Clinical Trials Directory